Cellectis SA (CLLS)
3.41
+0.03
(+0.89%)
USD |
NASDAQ |
Apr 02, 16:00
3.49
+0.08
(+2.35%)
After-Hours: 20:00
Cellectis SG&A Expense (Semi Annual)
SG&A Expense (Semi Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Semi Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Semi Annual) Benchmarks
| DBV Technologies SA | -- |
| EDAP TMS SA | -- |
| Sanofi | 5.874B |
| Akari Therapeutics Plc | -- |
| Biodexa Pharmaceuticals Plc | 3.292M |